A carregar...
A New Look at the 5α‐Reductase Inhibitor Finasteride
Finasteride is the first 5α‐reductase inhibitor that received clinical approval for the treatment of human benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern hair loss). These clinical applications are based on the ability of finasteride to inhibit the Type II isoform of the...
Na minha lista:
| Publicado no: | CNS Drug Rev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Inc
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741762/ https://ncbi.nlm.nih.gov/pubmed/16834758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2006.00053.x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|